$Kodiak Sciences(KOD.US)$ NEWS Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$Kodiak Sciences(KOD.US)$announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.
While Kodiak Sciences' cash runway is reassuring, its cash burn relative to its market cap is concerning. The company's high expenditure relative to its market value suggests an elevated risk of funding distress, making the stock a risky investment.
- 📈 Dow Jones extends its winning streak to six sessions, the longest since late July. - 🇺🇸 U.S. stocks had their best week of 2023. - 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%. - 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January. - 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%. - 📉 Bond yields tempo...
$Kodiak Sciences(KOD.US)$announces one-year topline data for its ABC Platform based investigational therapy tarcocimab tedromer from the pivotal BEACON study in patients with macular edema due to retinal vein occlusion (RVO)
$Kodiak Sciences(KOD.US)$I get the bad news yesterday,but surely they have more than that trail going on.I bought yesterday and of drops probably buy more because my opinion to oversold not to own some
Kodiak Sciences股票讨论区
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
- 🇺🇸 U.S. stocks had their best week of 2023.
- 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%.
- 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January.
- 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%.
- 📉 Bond yields tempo...
$Atlantica Sustainable Infrastructure(AY.US)$ $Vinco Ventures(BBIG.US)$ $碧迪医疗(BDX.US)$ $Bluejay Diagnostics(BJDX.US)$ $F5 Inc(FFIV.US)$ $赫氏(HXL.US)$ $直觉外科公司(ISRG.US)$ $Kodiak Sciences(KOD.US)$ $高斯电子(KOSS.US)$ $Marker Therapeutics(MRKR.US)$ $NeuroOne Medical(NMTC.US)$ $恩智浦(NXPI.US)$ $RLI保险(RLI.US)$ $特百惠(TUP.US)$ $惠而浦(WHR.US)$ $Expion360(XPON.US)$
暂无评论